← All Shuttle Pharmaceuticals Holdings, INC filings

Shuttle Pharmaceuticals Holdings, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharmaceuticals Holdings Insider Sells Shares
Hrt Financial Lp reported changes in beneficial ownership of Shuttle Pharmaceuticals Holdings, Inc. common stock on July 9, 2026.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharmaceuticals Holdings Insider Buys Shares
Hrt Financial Lp reported changes in beneficial ownership of Shuttle Pharmaceuticals Holdings, Inc. common stock on July 9, 2026.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharmaceuticals Holdings, Inc. Insider Trading Activity
HRT FINANCIAL LP reports significant transactions in Shuttle Pharmaceuticals Holdings, Inc. common stock.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharmaceuticals Holdings, Inc. Insider Trading Activity
HRT FINANCIAL LP reports significant stock transactions in Shuttle Pharmaceuticals Holdings, Inc., indicating changes in beneficial ownership.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: HRT Financial LP Acquires Shuttle Pharmaceuticals Stock
HRT Financial LP reports a significant acquisition of common stock in Shuttle Pharmaceuticals Holdings, Inc., increasing its beneficial ownership.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: HRT Financial LP Acquires Shuttle Pharmaceuticals Stock
HRT Financial LP reports significant stock acquisitions in Shuttle Pharmaceuticals Holdings, Inc. on June 29th and June 30th, 2026.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharma Director Gains 29,240 RSUs
Shuttle Pharmaceuticals Holdings, Inc. Director Steven M Richards was granted 29,240 Restricted Stock Units, vesting over three years.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharma Director Granted RSUs
Shuttle Pharmaceuticals Holdings, Inc. director Oleh Nabyt was granted 29,240 Restricted Stock Units, vesting over three years.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharma Director Granted 29,240 RSUs
Shuttle Pharmaceuticals Holdings, Inc. director George Scorsis was granted 29,240 Restricted Stock Units, vesting over three years.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharma Director Granted RSUs
Shuttle Pharmaceuticals Holdings, Inc. Director Joseph Tung was granted 29,240 Restricted Stock Units, vesting over three years.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharma CFO Granted Over 54,000 Restricted Stock Units
Shuttle Pharmaceuticals Holdings, Inc. CFO Timothy J. Lorber was granted 54,094 Restricted Stock Units with future vesting dates.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharmaceuticals Holdings Officer Mira Jung Reports Stock Disposal
Mira Jung, Chief Scientific Officer of Shuttle Pharmaceuticals Holdings, reports the disposal of 598 shares of Class A Common Stock on May 1, 2024, at a price of $11.28 per share.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharmaceuticals Director Sells Shares to Cover Tax Obligations
Director Chris Senanayake sold 1,626 shares of Shuttle Pharmaceuticals Holdings, Inc. to cover tax withholding obligations related to vesting restricted stock units.
NASDAQ
SHPH
Shuttle Pharmaceuticals Holdings, INC
Form 4: Shuttle Pharmaceuticals CFO Acquires 100,000 Shares of Common Stock
Michael Vander Hoek, CFO of Shuttle Pharmaceuticals Holdings, Inc., acquired 100,000 shares of common stock on March 8, 2024.